Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/5/24 16:05 | 3/4/24 | SBFM | Health | Drug | Pharmaceutical Preparations | Slilaty Steve N. | NY | DOT | CEO | P | 10 | 0.1000 | 0 | 100 | 333 | 130 | D | ||||||||||||||
2/12/24 16:05 | 2/8/24 | SBFM | Health | Drug | Pharmaceutical Preparations | Slilaty Steve N. | NY | DOT | CEO | P | 2 | 0.1000 | 0 | 20 | 200 | 30 | D | ||||||||||||||
12/2/22 06:01 | 11/30/22 | SBFM | Health | Biolab | Commercial Physical & Biologi | Sebaaly Camille | A8 | O | CFO,Secr | P | 23 | 0.7635 | 0 | 30 | 21 | 174 | D | ||||||||||||||
6/6/22 12:36 | 6/3/22 | SBFM | Health | Biolab | Commercial Physical & Biologi | Sebaaly Camille | A8 | O | CFO,Secr | P | 31 | 1.22 | 0 | 25 | 21 | 144 | D | ||||||||||||||
4/26/16 08:49 | 4/12/16 | SBFM | Health | Biolab | Commercial Physical & Biologi | Slilaty Steve N. | A8 | DO | CEO | P | 50 | 0.1976 | 0 | 253 | 1 | 42,955 | M | ||||||||||||||
6/1/15 20:26 | 5/27/15 | SBFM | BizSv | Conslt | Management Consulting Service | Slilaty Steve N. | A8 | DOT | CEO | P | 50 | 0.1000 | 0 | 500 | New | 500 | D | ||||||||||||||
9/7/12 20:00 | 9/4/12 | SBFM | BizSv | Conslt | Management Consulting Service | Slilaty Steve N. | A8 | DOT | CEO | S.d | -130 | 0.0500 | 0 | -2,592 | -4 | 65,627 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |